Supraventricular tachycardia (SVT) episodes result from abnormal electrical circuits in the atria or AV node, leading to sudden heart rates exceeding 150 beats per minute. These episodes originate above the ventricles, often triggered by premature electrical impulses or re-entry pathways.
SVT occurs when the heart's electrical system misfires. Normally, the sinoatrial (SA) node generates a steady rhythm. In SVT, an extra pathway or faulty node causes signals to loop rapidly between the atria and ventricles. This creates a sustained, fast heartbeat that can last seconds to hours.
Common triggers include caffeine, alcohol, stress, dehydration, and certain medications. Some people have congenital electrical abnormalities, such as Wolff-Parkinson-White (WPW) syndrome, which increases SVT risk. Episodes may start abruptly and stop just as suddenly, sometimes resolving with vagal maneuvers like the Valsalva maneuver.
Electrical activity in the heart follows a precise sequence. The SA node fires a signal that travels through the atria, pauses briefly at the AV node, then spreads to the ventricles. In SVT, this path becomes disrupted by an accessory pathway or abnormal automaticity in the AV node.
Re-entry is the most common mechanism. A premature impulse travels down the normal route but returns via an alternate, faster path, creating a closed loop. This loop sustains rapid firing-often 160-250 beats per minute-without resetting until interrupted.
For example, a 28-year-old woman reported feeling her heart "jump" during a stressful work meeting. Her ECG showed a regular, narrow-complex tachycardia at 180 bpm. She was diagnosed with AV nodal reentrant tachycardia (AVNRT), the most frequent form of SVT. The episode ended after she performed the Valsalva maneuver, which slowed conduction through the AV node.
Four main types of SVT exist, each with distinct underlying mechanisms:
| Type | Underlying Mechanism | Common Triggers | Prevalence |
|---|---|---|---|
| AVNRT | Re-entry within the AV node due to dual pathways | Stress, caffeine, sleep deprivation | ~60% |
| AVRT | Re-entry using an accessory pathway (e.g., WPW) | Alcohol, exercise, fatigue | ~30% |
| Atrial tachycardia | Abnormal automaticity in atrial tissue | Hyperthyroidism, electrolyte imbalance | ~5% |
| AT | Triggered activity or ectopic focus in atria | Medications (e.g., digoxin), ischemia | ~5% |
AVNRT accounts for the majority of cases. It typically affects young adults and women more frequently than men. AVRT, associated with WPW syndrome, carries higher risk of progressing to life-threatening rhythms like ventricular fibrillation if left untreated.
One patient with WPW experienced syncope during a basketball game. His ECG showed delta waves-a sign of pre-excitation-and he developed SVT at 220 bpm. He required catheter ablation to eliminate the accessory pathway.
SVT is often mistaken for anxiety attacks or panic disorder. Both can cause palpitations, sweating, and dizziness. However, SVT episodes feature a consistent, rapid pulse that doesn't fluctuate with breathing or emotional state. An ECG confirms the diagnosis.
Another confusion arises between SVT and ventricular tachycardia (VT). VT originates in the ventricles and is more dangerous. It typically presents with wide QRS complexes on ECG, unlike the narrow complexes seen in most SVT cases. Misdiagnosing VT as SVT can delay critical treatment.
Some patients assume all rapid heartbeats are SVT. But sinus tachycardia-driven by fever, anemia, or hyperthyroidism-is a physiological response, not an arrhythmia. It lacks the abrupt onset and termination typical of SVT.
I once observed a 35-year-old man who believed his racing heart was SVT. His resting ECG was normal. During a symptomatic episode, he had a heart rate of 140 bpm with irregular rhythm. Further testing revealed atrial fibrillation, not SVT. This highlights the importance of capturing the event on ECG rather than relying on symptoms alone.
Episodes lasting longer than 30 minutes, accompanied by chest pain, shortness of breath, or fainting, require urgent evaluation. Prolonged SVT can lead to cardiomyopathy or stroke due to reduced cardiac output.
The American Heart Association notes that recurrent SVT episodes increase the risk of heart failure over time. Patients with frequent episodes should undergo electrophysiological study to map the abnormal circuit and consider ablation therapy.
For individuals with known SVT, keeping a symptom diary helps identify patterns. Recording triggers such as late-night coffee, lack of sleep, or emotional stress improves management. Avoiding known triggers reduces episode frequency by up to 50%, according to a 2021 study in Heart Rhythm.
Once diagnosed, treatment options include vagal maneuvers, medications like beta-blockers or calcium channel blockers, and catheter ablation. Ablation cures SVT in over 95% of cases, according to the American College of Cardiology.